US$ 21.22
fda bpc-157 safety warning In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like and Melanotan II. The move comes as demand for “ normal dose of bpc 157
Description
According to the inspection report, one case involved a patient with severe gastrointestinal issues and a 3-night hospital stay after taking a compounded semaglutide injection

Nothing here says IGF-1 DES treats, cures, or improves any condition

Handa K, Inukai K, Onuma H, Kudo A, Nakagawa F, Tsugawa K,

European journal of endocrinology , 139 (5), 552561
